Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
62.90
0.00 (0.00%)
Jul 30, 2026, 11:41 AM CST

Shine-On BioMedical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3030-9.52--
Revenue Growth
------
Gross Profit
3030-6.67--
Operating Income
-125.5-125.5-136.07-62.68-18.61-11.5
Net Income
-110.29-110.29-118.89-37.17-19.54-11.24
Earnings Per Share
-2.21-2.21-2.39-0.75-0.43-0.61
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
922.17922.171,0441,1371,166905.98
Total Debt
1.361.362.60.541.522.48
Net Cash (Debt)
920.81920.811,0411,1361,165903.5
Net Cash Growth
-3.55%-11.55%-8.40%-2.42%28.90%-
Net Cash Per Share
18.4518.4520.9022.8225.6548.91

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-114.75-114.75-91.45-26.88-21.66-8.46
Capital Expenditures
-0.03-0.03-0.11-0.07-0.48-2.25
Free Cash Flow
-114.78-114.78-91.56-26.95-22.14-10.71
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-70.00%--
Operating Margin
-418.33%-418.33%--658.16%--
Pretax Margin
-368.06%-368.06%--366.82%--
Profit Margin
-367.62%-367.62%--390.23%--
FCF Margin
-382.59%-382.59%--282.94%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
104.41116.20-362.89--